As one of India’s largest architectural and engineering firms, executing over 80 biopharmaceutical projects, IPS-Mehtalia offers biopharmaceutical expertise spanning research to formulation to pilot to large-scale biotechnology production and pharmaceutical manufacturing facilities.
Our technical expertise and outstanding project execution enables us to assist local and multi-national pharmaceutical and biotechnology clients to significantly improve operational capabilities, throughput and process control, optimize cost and minimize risk. We specialize in complying with FDA and EU current good manufacturing practice (cGMP) and international regulatory guidelines to help launch new products in the market.
Our team has led product development, research and documentation to meet bio/pharmaceutical industry regulations and other regulatory authorities to launch new products in the market. Currently, we are executing the engineering and construction management of one of the largest pharmaceutical projects in India, a sterile manufacturing facility. IPS-Mehtalia designed and built a “Greenfield” state-of-the-art manufacturing and process research complex which was awarded ISPE’s 2012 Facility of the Year for Project Execution.